Company intelligence / Profile preview

Hapten Sciences

Memphis, Tennessee, United Stateshaptensciences.com ↗

Ownership: Private
Employees: ~10
Development stage: Other

Overview

Hapten Sciences is developing novel, early-stage products for dermatological conditions. The company has completed API manufacturing and filed an IND application, indicating readiness for human clinical trials. No published clinical results are available yet.

Therapeutic areas: Dermatology
Modalities: Small molecules (inferred from focus on dermatological drugs and early-stage medicines)
Industry: Biotech

Drug pipeline

1 asset

PDC-APB

Beyond the preview

Go deeper on Hapten Sciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hapten Sciences.

Explore the full profile